Cell-based therapies for epidermolysis bullosa-From bench to bedside;Zellbasierte Therapien bei Epidermolysis bullosa-vom Labor zum Patienten

JDDG - Journal of the German Society of Dermatology

Volumn 10, Issue 11, 2012, Pages 803-807

  Uitto, Jouni ^a   Has, Cristina ^b   Bruckner Tuderman, Leena ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

bone marrow transplantation; epidermolysis bullosa; heritable blistering diseases; stem cell therapy

Indexed keywords

COLLAGEN TYPE 7; COLLAGEN TYPE 7 A1; KALININ; LAMININ; LAMININ BETA3; UNCLASSIFIED DRUG;

BONE MARROW TRANSPLANTATION; CELL THERAPY; CLINICAL FEATURE; EPIDERMOLYSIS BULLOSA; EX VIVO GENE TRANSFER; FIBROBLAST; FIBROBLAST THERAPY; GENE MUTATION; KERATINOCYTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUTATIONAL ANALYSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PLURIPOTENT STEM CELL TRANSPLANTATION; REVIEW; STEM CELL TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; EPIDERMOLYSIS BULLOSA; HUMANS; STEM CELL TRANSPLANTATION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84868304859     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2012.08035.x     Document Type: Review

References (16)

1. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G,. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58: 931-50.
2. Uitto J, McGrath JA, Rodeck U, Bruckner-Tuderman L, Robinson EC,. Progress in epidermolysis bullosa research: toward treatment and cure. J Invest Dermatol 2010; 130: 1778-84.
3. Uitto J,. Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies. Acta Derm Venereol 2009; 89: 228-35.
4. Uitto J, Christiano AM, McLean WH, McGrath JA,. Novel molecular therapies for heritable skin disorders. J Invest Dermatol 2012; 132: 820-8.
5. Woodley DT, Krueger GG, Jorgensen CM, Fairley JA, Atha T, Huang Y, Chan L, Keene DR, Chen M,. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 2003; 121: 1021-8.
6. Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J, Elia G, Jeffery R, Leigh IM, Navsaria H, McGrath JA,. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008; 128: 2179-89.
7. Nagy N, Almaani N, Tanaka A, Lai-Cheong JE, Techanukul T, Mellerio JE, McGrath JA,. HB-EGF Induces COL7A1 Expression in Keratinocytes and Fibroblasts: Possible Mechanism Underlying Allogeneic Fibroblast Therapy in Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol 2011; 131: 1771-74.
8. Kern JS, Loeckermann S, Fritsch A, Hausser I, Roth W, Magin TM, Mack C, Muller ML, Paul O, Ruther P, Bruckner-Tuderman L,. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther 2009; 17: 1605-15.
9. Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, Gonzalez S, Yubero MJ,. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010; 12: 429-31.
10. Itoh M, Kiuru M, Cairo MS, Christiano AM,. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA. 2011; 108 (21): 8797-802.
11. Tolar J, Xia L, Riddle MJ, Lees CJ, Eide CR, McElmurry RT, Titeux M, Osborn MJ, Lund TC, Hovnanian A, Wagner JE, Blazar BR,. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011; 131: 848-56.
12. Chino T, Tamai K, Yamazaki T, Otsuru S, Kikuchi Y, Nimura K, Endo M, Nagai M, Uitto J, Kitajima Y, Kaneda Y,. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 2008; 173: 803-14.
13. Tolar J, Ishida-Yamamoto A, Riddle M, McElmurry RT, Osborn M, Xia L, Lund T, Slattery C, Uitto J, Christiano AM, Wagner JE, Blazar BR,. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 2009; 113: 1167-74.
14. Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, Woodley DT, Chen M, Riddle MJ, Osborn MJ, Lund T, Dolan M, Blazar BR, Tolar J,. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363: 629-39.
15. Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, Maruggi G, Ferrari G, Provasi E, Bonini C, Capurro S, Conti A, Magnoni C, Giannetti A, De Luca M,. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006; 12: 1397-402.
16. De Luca M, Pellegrini G, Mavilio F,. Gene therapy of inherited skin adhesion disorders: a critical overview. Br J Dermatol 2009; 161: 19-24.